D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 88 Citations 26,378 297 World Ranking 8437 National Ranking 241

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Gene
  • Enzyme

Irène Juhan-Vague mostly deals with Internal medicine, Endocrinology, Plasminogen activator, Plasminogen activator inhibitor-1 and Insulin resistance. Internal medicine and Surgery are commonly linked in her work. Her study brings together the fields of Activator and Endocrinology.

The Plasminogen activator study combines topics in areas such as Thrombosis, Tissue plasminogen activator and Immunology. The various areas that Irène Juhan-Vague examines in her Insulin resistance study include Low-density lipoprotein and Weight loss. The concepts of her Fibrinolysis study are interwoven with issues in Gastroenterology, Antigen and Fibrin.

Her most cited work include:

  • Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. (956 citations)
  • Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. (555 citations)
  • Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis (524 citations)

What are the main themes of her work throughout her whole career to date?

Irène Juhan-Vague spends much of her time researching Internal medicine, Endocrinology, Plasminogen activator inhibitor-1, Plasminogen activator and Fibrinolysis. Her work deals with themes such as Gastroenterology and Cardiology, which intersect with Internal medicine. Irène Juhan-Vague regularly ties together related areas like Fibrinogen in her Endocrinology studies.

Much of her study explores Plasminogen activator inhibitor-1 relationship to Molecular biology. Her Plasminogen activator research includes themes of Tissue plasminogen activator and Immunology. Irène Juhan-Vague has included themes like Antigen and Fibrin in her Fibrinolysis study.

She most often published in these fields:

  • Internal medicine (59.28%)
  • Endocrinology (43.00%)
  • Plasminogen activator inhibitor-1 (22.15%)

What were the highlights of her more recent work (between 2004-2018)?

  • Internal medicine (59.28%)
  • Endocrinology (43.00%)
  • Immunology (16.29%)

In recent papers she was focusing on the following fields of study:

Her scientific interests lie mostly in Internal medicine, Endocrinology, Immunology, Metabolic syndrome and Myocardial infarction. Her Internal medicine research includes elements of Diabetes mellitus and Cardiology. Insulin resistance, Adipose tissue, Plasminogen activator inhibitor-1, Plasminogen activator and Insulin are the subjects of her Endocrinology studies.

Irène Juhan-Vague usually deals with Immunology and limits it to topics linked to Cell biology and Furin, Ectodomain and Transmembrane protein. Her studies in Metabolic syndrome integrate themes in fields like Single-nucleotide polymorphism, Type 2 diabetes and Haplotype. Her work carried out in the field of Myocardial infarction brings together such families of science as Genotype, Surgery, Cohort and C-reactive protein.

Between 2004 and 2018, her most popular works were:

  • Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. (956 citations)
  • C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet (293 citations)
  • PAI-1 and the Metabolic Syndrome. Links, Causes, and Consequences (280 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Enzyme

Irène Juhan-Vague mainly investigates Internal medicine, Endocrinology, Immunology, Platelet and Adipose tissue. Many of her studies involve connections with topics such as Cardiology and Internal medicine. Her Metabolic syndrome study in the realm of Endocrinology interacts with subjects such as Lipoprotein receptor-related protein.

Irène Juhan-Vague interconnects Endothelium, Neuroinflammation and Cell biology in the investigation of issues within Platelet. Her research in Adipose tissue intersects with topics in Plasminogen activator and Insulin resistance. Her Plasminogen activator research is multidisciplinary, incorporating elements of Obesity and Insulin receptor.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

J Danesh;S Lewington;S G Thompson;Lowe Gdo..
JAMA (2005)

1487 Citations

Production of plasminogen activator inhibitor 1 by human adipose tissue : Possible link between visceral fat accumulation and vascular disease

M C Alessi;F Peiretti;P Morange;M Henry.
Diabetes (1997)

882 Citations

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

I. Juhan-Vague;M. C. Alessi;P. Vague.
Diabetologia (1991)

804 Citations

Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay.

Paul Declerck;M C Alessi;M Verstreken;E K O Kruithof.
Blood (1988)

803 Citations

Correlation Between Blood Fibrinolytic Activity, Plasminogen Activator Inhibitor Level, Plasma Insulin Level, and Relative Body Weight in Normal and Obese Subjects

Philippe Vague;Irène Juhan-Vague;Marie Francoise Aillaud;Christian Badier.
Metabolism-clinical and Experimental (1986)

649 Citations

PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular Events

I Juhan-Vague;M C Alessi.
Thrombosis and Haemostasis (1997)

556 Citations

Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.

I Juhan-Vague;J Valadier;M C Alessi;M F Aillaud.
Thrombosis and Haemostasis (1987)

546 Citations

C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease The PRIME Study

Gérald Luc;Jean-Marie Bard;Irène Juhan-Vague;Jean Ferrieres.
Arteriosclerosis, Thrombosis, and Vascular Biology (2003)

533 Citations

PAI-1 and the Metabolic Syndrome. Links, Causes, and Consequences

Marie-Christine Alessi;Irène Juhan-Vague.
Arteriosclerosis, Thrombosis, and Vascular Biology (2006)

460 Citations

Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.

Marie-Christine Alessi;Delphine Bastelica;Pierre Morange;Bruno Berthet.
Diabetes (2000)

446 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Irène Juhan-Vague

Gordon D.O. Lowe

Gordon D.O. Lowe

University of Glasgow

Publications: 94

Paul Declerck

Paul Declerck

KU Leuven

Publications: 86

David-Alexandre Trégouët

David-Alexandre Trégouët

University of Bordeaux

Publications: 81

Desire Collen

Desire Collen

KU Leuven

Publications: 74

Russell P. Tracy

Russell P. Tracy

University of Vermont

Publications: 72

Georges E. Grau

Georges E. Grau

University of Sydney

Publications: 71

Marie-Christine Alessi

Marie-Christine Alessi

Aix-Marseille University

Publications: 69

Aaron R. Folsom

Aaron R. Folsom

University of Minnesota

Publications: 59

Mary Cushman

Mary Cushman

University of Vermont

Publications: 56

Douglas E. Vaughan

Douglas E. Vaughan

Northwestern University

Publications: 54

Burton E. Sobel

Burton E. Sobel

Washington University in St. Louis

Publications: 50

Ann Rumley

Ann Rumley

University of Glasgow

Publications: 49

Peter J. Grant

Peter J. Grant

University of Leeds

Publications: 48

Anders Hamsten

Anders Hamsten

Karolinska Institute

Publications: 48

David J. Loskutoff

David J. Loskutoff

Scripps Research Institute

Publications: 39

Paul M. Ridker

Paul M. Ridker

Brigham and Women's Hospital

Publications: 38

Trending Scientists

Chris Cornelis

Chris Cornelis

Ghent University

Ming-Ting Sun

Ming-Ting Sun

University of Washington

Degang Chen

Degang Chen

North China Electric Power University

Christian Sohler

Christian Sohler

University of Cologne

Jun-Yan Zhu

Jun-Yan Zhu

Carnegie Mellon University

A. C. Fernandez-Pello

A. C. Fernandez-Pello

University of California, Berkeley

Salvatore Coluccia

Salvatore Coluccia

University of Turin

Julie Williams

Julie Williams

Cardiff University

Themis J. Michailides

Themis J. Michailides

University of California, Davis

Karl H.J. Gordon

Karl H.J. Gordon

Commonwealth Scientific and Industrial Research Organisation

James L. N. Wood

James L. N. Wood

University of Cambridge

Jean-Luc Probst

Jean-Luc Probst

Paul Sabatier University

Alan G. Green

Alan G. Green

ETH Zurich

Tinnakorn Chaiworapongsa

Tinnakorn Chaiworapongsa

Wayne State University

D. L. Burke

D. L. Burke

Stanford University

Linda J. Tacconi

Linda J. Tacconi

Max Planck Society

Something went wrong. Please try again later.